Recent progress on targeting the αvβ1 integrin for the treatment of tissue fibrosis. [electronic resource]
- Expert opinion on drug discovery 08 2016
- 749-51 p. digital
Publication Type: Editorial
1746-045X
10.1080/17460441.2016.1193486 doi
Animals Drug Design Extracellular Matrix--metabolism Fibrosis--drug therapy Humans Receptors, Vitronectin--metabolism